Sarah Richtmann

7PUBLICATIONS
25CO-AUTHORS
Molecular targetsGene expression (incl. microarray and other genome-wide approaches)MechanobiologyPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2026
Bladder cancer precision-cut tumor slices (PCTS) preserve functional immune microenvironment enabling ex vivo drug evaluation.

|Jun 19, 2024
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.

Viktor Sincic, Ken F Arlenhold, Sarah Richtmann

|Jun 09, 2023
Is iron deficiency caused by

Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin

|Sep 23, 2022
Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and SREBF1 Gene.

Anna Ricarda Gründing, Marc A Schneider, Sarah Richtmann

|May 28, 2022
Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?

Vivienne Theobald, Nicola Benjamin, Hans-Jürgen Seyfarth

|Dec 01, 2020
Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis.

Miriam M Küster, Marc A Schneider, Antje M Richter

Pageof 2

Frequent Collaborators

4 joint publications

Marc A Schneider

2 joint publications

Mark Kriegsmann

2 joint publications

Kristina Lundberg

1 joint publications

Petros Christopoulos